Copyright Reports & Markets. All rights reserved.

Global Contrast Media Injector in Vascular Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Contrast Media Injector in Vascular Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Contrast Media Injector in Vascular Market Size Growth Rate by Product
      • 1.4.2 Single-head Contrast Media Injector
      • 1.4.3 Dual-head Contrast Media Injector
    • 1.5 Market by End User
      • 1.5.1 Global Contrast Media Injector in Vascular Market Size Growth Rate by End User
      • 1.5.2 Cardiology
      • 1.5.3 Oncology
      • 1.5.4 Neurology
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Contrast Media Injector in Vascular Market Size
      • 2.1.1 Global Contrast Media Injector in Vascular Revenue 2014-2025
      • 2.1.2 Global Contrast Media Injector in Vascular Sales 2014-2025
    • 2.2 Contrast Media Injector in Vascular Growth Rate by Regions
      • 2.2.1 Global Contrast Media Injector in Vascular Sales by Regions
      • 2.2.2 Global Contrast Media Injector in Vascular Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Contrast Media Injector in Vascular Sales by Manufacturers
      • 3.1.1 Contrast Media Injector in Vascular Sales by Manufacturers
      • 3.1.2 Contrast Media Injector in Vascular Sales Market Share by Manufacturers
      • 3.1.3 Global Contrast Media Injector in Vascular Market Concentration Ratio (CR5 and HHI)
    • 3.2 Contrast Media Injector in Vascular Revenue by Manufacturers
      • 3.2.1 Contrast Media Injector in Vascular Revenue by Manufacturers (2014-2019)
      • 3.2.2 Contrast Media Injector in Vascular Revenue Share by Manufacturers (2014-2019)
    • 3.3 Contrast Media Injector in Vascular Price by Manufacturers
    • 3.4 Contrast Media Injector in Vascular Manufacturing Base Distribution, Product Types
      • 3.4.1 Contrast Media Injector in Vascular Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Contrast Media Injector in Vascular Product Type
      • 3.4.3 Date of International Manufacturers Enter into Contrast Media Injector in Vascular Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Contrast Media Injector in Vascular Sales by Product
    • 4.2 Global Contrast Media Injector in Vascular Revenue by Product
    • 4.3 Contrast Media Injector in Vascular Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Contrast Media Injector in Vascular Breakdown Data by End User

    6 North America

    • 6.1 North America Contrast Media Injector in Vascular by Countries
      • 6.1.1 North America Contrast Media Injector in Vascular Sales by Countries
      • 6.1.2 North America Contrast Media Injector in Vascular Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Contrast Media Injector in Vascular by Product
    • 6.3 North America Contrast Media Injector in Vascular by End User

    7 Europe

    • 7.1 Europe Contrast Media Injector in Vascular by Countries
      • 7.1.1 Europe Contrast Media Injector in Vascular Sales by Countries
      • 7.1.2 Europe Contrast Media Injector in Vascular Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Contrast Media Injector in Vascular by Product
    • 7.3 Europe Contrast Media Injector in Vascular by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Contrast Media Injector in Vascular by Countries
      • 8.1.1 Asia Pacific Contrast Media Injector in Vascular Sales by Countries
      • 8.1.2 Asia Pacific Contrast Media Injector in Vascular Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Contrast Media Injector in Vascular by Product
    • 8.3 Asia Pacific Contrast Media Injector in Vascular by End User

    9 Central & South America

    • 9.1 Central & South America Contrast Media Injector in Vascular by Countries
      • 9.1.1 Central & South America Contrast Media Injector in Vascular Sales by Countries
      • 9.1.2 Central & South America Contrast Media Injector in Vascular Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Contrast Media Injector in Vascular by Product
    • 9.3 Central & South America Contrast Media Injector in Vascular by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Contrast Media Injector in Vascular by Countries
      • 10.1.1 Middle East and Africa Contrast Media Injector in Vascular Sales by Countries
      • 10.1.2 Middle East and Africa Contrast Media Injector in Vascular Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Contrast Media Injector in Vascular by Product
    • 10.3 Middle East and Africa Contrast Media Injector in Vascular by End User

    11 Company Profiles

    • 11.1 Bayer
      • 11.1.1 Bayer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Bayer Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Bayer Contrast Media Injector in Vascular Products Offered
      • 11.1.5 Bayer Recent Development
    • 11.2 Bracco
      • 11.2.1 Bracco Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Bracco Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Bracco Contrast Media Injector in Vascular Products Offered
      • 11.2.5 Bracco Recent Development
    • 11.3 Nemoto
      • 11.3.1 Nemoto Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Nemoto Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Nemoto Contrast Media Injector in Vascular Products Offered
      • 11.3.5 Nemoto Recent Development
    • 11.4 Guerbet
      • 11.4.1 Guerbet Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Guerbet Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Guerbet Contrast Media Injector in Vascular Products Offered
      • 11.4.5 Guerbet Recent Development
    • 11.5 Ulrich medical
      • 11.5.1 Ulrich medical Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Ulrich medical Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Ulrich medical Contrast Media Injector in Vascular Products Offered
      • 11.5.5 Ulrich medical Recent Development
    • 11.6 APOLLO RT
      • 11.6.1 APOLLO RT Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 APOLLO RT Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 APOLLO RT Contrast Media Injector in Vascular Products Offered
      • 11.6.5 APOLLO RT Recent Development
    • 11.7 MEDTRON
      • 11.7.1 MEDTRON Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 MEDTRON Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 MEDTRON Contrast Media Injector in Vascular Products Offered
      • 11.7.5 MEDTRON Recent Development
    • 11.8 Anke High-Tech
      • 11.8.1 Anke High-Tech Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Anke High-Tech Contrast Media Injector in Vascular Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Anke High-Tech Contrast Media Injector in Vascular Products Offered
      • 11.8.5 Anke High-Tech Recent Development

    12 Future Forecast

    • 12.1 Contrast Media Injector in Vascular Market Forecast by Regions
      • 12.1.1 Global Contrast Media Injector in Vascular Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Contrast Media Injector in Vascular Revenue Forecast by Regions 2019-2025
    • 12.2 Contrast Media Injector in Vascular Market Forecast by Product
      • 12.2.1 Global Contrast Media Injector in Vascular Sales Forecast by Product 2019-2025
      • 12.2.2 Global Contrast Media Injector in Vascular Revenue Forecast by Product 2019-2025
    • 12.3 Contrast Media Injector in Vascular Market Forecast by End User
    • 12.4 North America Contrast Media Injector in Vascular Forecast
    • 12.5 Europe Contrast Media Injector in Vascular Forecast
    • 12.6 Asia Pacific Contrast Media Injector in Vascular Forecast
    • 12.7 Central & South America Contrast Media Injector in Vascular Forecast
    • 12.8 Middle East and Africa Contrast Media Injector in Vascular Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Contrast Media Injector in Vascular Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Contrast delivery is most effective and efficient using a medical device called a “power injector” that can be programmed to deliver specific amounts of contrast media. This “power injector” is the Contrast Injector.
      Contrast Media Injector in Vascular can be used to look at the arteries or veins in the head, arms, legs, chest, back, or belly.
      Market competition is not intense. Bayer, Bracco, Nemoto, Guerbet, Ulrich medical, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
      Europe region is the largest supplier of Contrast Media Injector in Vascular, with a production market share nearly 37% in 2016. North America is the second largest supplier of Contrast Media Injector in Vascular, enjoying production market share nearly 28% in 2016.
      North America is the largest consumption place, with a consumption market share nearly 34% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 34%.
      The global Contrast Media Injector in Vascular market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Contrast Media Injector in Vascular market based on company, product type, end user and key regions.

      This report studies the global market size of Contrast Media Injector in Vascular in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Contrast Media Injector in Vascular in these regions.
      This research report categorizes the global Contrast Media Injector in Vascular market by top players/brands, region, type and end user. This report also studies the global Contrast Media Injector in Vascular market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Bayer
      Bracco
      Nemoto
      Guerbet
      Ulrich medical
      APOLLO RT
      MEDTRON
      Anke High-Tech

      Market size by Product
      Single-head Contrast Media Injector
      Dual-head Contrast Media Injector
      Market size by End User
      Cardiology
      Oncology
      Neurology

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Contrast Media Injector in Vascular market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Contrast Media Injector in Vascular market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Contrast Media Injector in Vascular companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Contrast Media Injector in Vascular submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Contrast Media Injector in Vascular are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contrast Media Injector in Vascular market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now